mrna Archives

Featured image of the article Arcturus Therapeutics Achieve EMA Approval Recommendation for KOSTAIVE®, a Breakthrough Self-Amplifying RNA Vaccine.

Arcturus Therapeutics Achieve EMA Approval Recommendation for KOSTAIVE®, a Breakthrough Self-Amplifying RNA Vaccine

Posted on February 4, 2025 by knowmade

SOPHIA ANTIPOLIS, France – February 04, 2025 │ KnowMade actively tracks therapeutic mRNA innovations as part of its Therapeutic mRNA patent monitoring services. What’s new today? CHMP Recommends Approval of KOSTAIVE® (ARCT-154) EMA opinion The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval[…]

Patenting Activity in 2024: An Insightful Analysis

Posted on January 30, 2025February 4, 2025 by knowmade

SOPHIA ANTIPOLIS, France – January 30, 2025 │ The last quarterly report for the 2024 Therapeutic mRNA patent monitor is now available! As we leave behind another year, we look back on the mRNA therapeutic patenting activity! The year 2024 marked another dynamic period for technological innovation in mRNA therapeutic area, the race for intellectual[…]

Continued Innovation in mRNA Technology: Key Trends from Q4 2024 Patent Monitor

Posted on January 20, 2025January 30, 2025 by knowmade

SOPHIA ANTIPOLIS, France – January 20, 2025 │ The therapeutic RNA landscape continues to evolve with a robust pace of innovation. The latest Q4 2024 edition of our Therapeutic mRNA patent monitor highlights significant developments in intellectual property activities, shedding light on key contributors and trends in this dynamic field. Key Highlights from Q4 2024[…]

AGS Therapeutics: The French Biotech Disrupting mRNA Delivery with Microalgae Tech

Posted on November 5, 2024November 5, 2024 by knowmade

SOPHIA ANTIPOLIS, France – November 05, 2024 │ The last quarterly report for the 2024 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. AGS Therapeutics: Pioneering Microalgae-Based Drug Delivery for Therapeutic mRNA AGS therapeutic, a French newcomer to follow Identified[…]